what is the glp 1 receptor GLP-1 agonists show promise in treating substance use disorders New Insights into Beta-Cell GLP-1

doi: 10.1111/dom.12885 Summary Keywords lipodystrophy, glucagon-like peptide-1, diabetes, seipin, liraglutide Citation Roumane A, Mcilroy GD, Sommer N, Han W, Heisler LK and Rochford JJ (2024) GLP-1 receptor agonist improves metabolic disease in a pre-clinical model of lipodystrophy

A second study suggests the cardiovascular benefits of GLP-1 drugs may operate through mechanisms independent of weight reduction, a finding with potentially significant implications for how physicians manage patients on these medications

However, non-specific binding can occur, requiring optimized imidazole elution gradients

Confirm the exact ratio with the manufacturers documentation before determining the liquid-to-peptide volume ratios for your laboratory equipment